| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 3 | 0 | 9 | 5 | 4 | 5 | 4 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 8 | 8 | 4 | 3 | 6 | 9 | 9 | 5 | 13 | 16 | 16 | 16 | 19 | 21 | 17 | 11 | 8 | 10 | 8 | 11 | 8 | 10 | 11 | 13 | 12 | 13 | 10 | 9 |
| Expenses | 3 | 0 | 7 | 4 | 4 | 4 | 3 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 14 | 5 | 7 | 8 | 11 | 10 | 12 | 14 | 14 | 9 | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 10 | 9 | 10 | 10 | 11 |
| EBITDA | 1 | 0 | 2 | 1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | -1 | -1 | 0 | 2 | -5 | 1 | 6 | 9 | 5 | 6 | 7 | 7 | 3 | 2 | -0 | 2 | -1 | 2 | 1 | 1 | 1 | 3 | 3 | 2 | -0 | -1 |
| Operating Profit % | 20 % | 0 % | 16 % | 19 % | -17 % | 16 % | 17 % | 17 % | 16 % | 9 % | 21 % | 21 % | 13 % | 22 % | 29 % | 32 % | -15 % | -42 % | -6 % | 23 % | -95 % | 15 % | 38 % | 53 % | 32 % | 36 % | 34 % | 32 % | -18 % | 12 % | -5 % | 15 % | -13 % | 20 % | 7 % | 10 % | 9 % | 25 % | 22 % | 17 % | -4 % | -20 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Profit Before Tax | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -2 | -3 | -2 | 1 | -7 | -1 | 4 | 7 | 4 | 5 | 5 | 6 | 2 | 0 | -2 | 0 | -3 | 1 | -1 | -1 | -1 | 2 | 1 | 0 | -3 | -4 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -1 | -0 | 0 | -1 | -0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 1 | 1 | 0 | -1 | -1 |
| Net Profit | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -0 | 0 | 1 | 1 | -2 | -2 | -1 | 0 | -6 | -1 | 3 | 6 | 4 | 3 | 4 | 4 | 1 | 0 | -1 | 0 | -2 | 1 | -1 | -1 | -1 | 1 | 0 | 0 | -1 | -3 |
| EPS in ₹ | 0.70 | 0.00 | 1.50 | 0.25 | -1.77 | 0.16 | 0.20 | 0.24 | 0.51 | 0.03 | 0.09 | 0.12 | -0.05 | 0.26 | 0.93 | 0.52 | -0.97 | -1.37 | -0.95 | 0.26 | -3.56 | -0.37 | 1.79 | 3.74 | 2.56 | 2.17 | 2.45 | 2.80 | 0.52 | 0.25 | -0.78 | 0.04 | -1.51 | 0.33 | -0.39 | -0.31 | -0.47 | 0.66 | 0.16 | 0.03 | -0.81 | -2.03 |
Jeevan Scientific Technology
Jeevan Scientific Technology
63.00
-1.96
(-3.02%)
Key Fundamentals
Market Cap
99.80 Cr
EPS
-0.04
PE Ratio
-24.61
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
66.89
52 Week Low
32.85
PB Ratio
2.06
Debt to Equity
0.35
Sector
Healthcare Technology Actual
Company News
View All News
Jeevan Scientific Technology Limited has scheduled an Extra-Ordinary General Meeting for November 12, 2025, to address several key corporate actions. The company plans to increase its authorized share capital from Rs 21 crores to Rs 25 crores and issue 35 lakh convertible warrants at Rs 40 per warrant to promoters and non-promoters, raising Rs 14 crores. Additionally, the company will issue 41.85 lakh equity shares at Rs 40 per share to non-promoters, raising Rs 16.74 crores. The total fundraising amounts to Rs 30.74 crores, intended for capital expenditure, working capital requirements, subsidiary operations, acquisition of API/formulation units, and general corporate purposes. The company will also adopt a new Memorandum of Association under the Companies Act 2013 and change its registered office state from Andhra Pradesh to Telangana. The relevant date for pricing is October 13, 2025, and the cut-off date for e-voting is November 5, 2025.
Jeevan Scientific Technology Limited's Board approved multiple capital-raising initiatives during its meeting on October 15, 2025. The company plans to issue up to 35,00,000 convertible warrants at Rs. 40 per warrant to both promoters and non-promoters, raising approximately Rs. 14 crores. Additionally, the Board approved issuing up to 41,85,000 equity shares to non-promoters at Rs. 40 per share, generating around Rs. 16.74 crores. The convertible warrants must be converted to equity shares within 18 months or face forfeiture. The company also decided to increase its authorized share capital from Rs. 21 crores to Rs. 25 crores and adopt a new Memorandum of Association. Post-allotment, promoters will hold 38.37% while public shareholders will hold 61.63% of the company. An Extraordinary General Meeting is scheduled for November 12, 2025, to seek shareholder approval for these proposals. The Board also reconstituted various committees including Audit, Nomination and Remuneration, Stakeholder Relationship, Risk Management, and Corporate Social Responsibility committees.
Jeevan Scientific Technology Reports Q2 2025 Loss, Approves Board Changes and ESOP GrantAug 14, 2025
Jeevan Scientific Technology Limited reported a standalone net loss of Rs 215.99 lakhs for Q2 2025 compared to a profit of Rs 160.08 lakhs in Q2 2024. Revenue declined to Rs 821.57 lakhs from Rs 1,251.66 lakhs year-over-year. The board approved reappointment of Krishna Kishore Kuchipudi as Managing Director for 3 years from April 2026 at Rs 9 lakhs monthly remuneration. Gollapinni Mallikarjuna was appointed as Independent Director, while Thammareddy Ravi resigned due to personal commitments. The company granted 3 lakh stock options to employees under ESOP Scheme 2016. Annual General Meeting is scheduled for September 27, 2025.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
660.90 | #1 26,630.27 | 50.98 | #1 3,714.20 | 3.77 | #1 496 | 14.53 | 49.37 | |
545.95 | 13,110.42 | 30.60 | 2,946.50 | 10.53 | 407 | 32.73 | 41.24 | |
196.33 | 4,466.00 | -24.36 | 17.60 | -46.34 | -161 | -83.93 | 34.81 | |
672.80 | 2,996.71 | 49.84 | 322.30 | 0.22 | 41 | #1 112.87 | 42.56 | |
23.77 | 351.64 | 8.31 | 10.20 | - | 1 | 76.32 | 93.61 | |
101.41 | 238.76 | -4.61 | 806.50 | 4.78 | -56 | 34.67 | 59.13 | |
63.00 | #7 99.80 | #1 -24.61 | #6 47.50 | #2 17.87 | #6 0 | #8 -420.00 | 91.29 | |
19.13 | 26.30 | 33.09 | 84.00 | 5.00 | 2 | -92.68 | 26.43 | |
27.95 | 19.87 | -1.50 | 1.96 | #1 40.00 | -13 | -566.67 | 53.25 |
Growth Rate
Revenue Growth
17.87 %
Net Income Growth
-107.69 %
Cash Flow Change
248.44 %
ROE
-104.40 %
ROCE
-353.70 %
EBITDA Margin (Avg.)
29.32 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 |
| Fixed Assets | 9 | 16 | 28 | 33 | 31 | 27 | 19 | 25 | 27 | 35 |
| Current Assets | 11 | 14 | 21 | 25 | 18 | 34 | 54 | 29 | 25 | 29 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 15 | 21 | 29 | 23 | 39 | 59 | 39 | 38 | 39 |
| Total Liabilities | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 |
| Current Liabilities | 8 | 9 | 17 | 21 | 23 | 23 | 22 | 11 | 9 | 12 |
| Non Current Liabilities | 8 | 5 | 10 | 8 | 8 | 8 | 5 | 6 | 10 | 16 |
| Total Equity | 4 | 17 | 22 | 32 | 23 | 35 | 51 | 48 | 49 | 50 |
| Reserve & Surplus | -2 | 3 | 7 | 17 | 8 | 20 | 35 | 33 | 33 | 34 |
| Share Capital | 6 | 9 | 12 | 15 | 15 | 15 | 15 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 1 | 2 | -2 | 4 | 24 | -23 | -6 | -0 |
| Investing Activities | -4 | -9 | -14 | -8 | -2 | -1 | -1 | -7 | -12 | -16 |
| Operating Activities | 4 | -6 | 6 | 4 | 0 | 5 | 20 | -6 | 3 | 10 |
| Financing Activities | 0 | 15 | 10 | 6 | 0 | -0 | 6 | -10 | 2 | 5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 38.11 % | 38.11 % | 38.11 % | 38.11 % | 36.15 % | 36.47 % | 36.47 % | 36.85 % | 38.44 % | 38.48 % | 38.48 % | 38.48 % | 38.70 % | 38.70 % | 38.70 % | 37.84 % | 38.05 % | 38.05 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 48.08 % | 45.99 % | 46.82 % | 46.70 % | 48.56 % | 48.38 % | 44.89 % | 44.65 % | 42.87 % | 42.89 % | 45.98 % | 45.51 % | 45.50 % | 45.34 % | 45.75 % | 45.91 % | 42.99 % | 42.75 % |
| Others | 13.81 % | 15.90 % | 15.06 % | 15.18 % | 15.29 % | 15.15 % | 18.64 % | 18.50 % | 18.69 % | 18.63 % | 15.53 % | 16.00 % | 15.80 % | 15.96 % | 15.55 % | 16.25 % | 18.96 % | 19.21 % |
| No of Share Holders | 2,740 | 3,999 | 5,499 | 5,813 | 6,144 | 6,439 | 6,449 | 6,295 | 6,061 | 5,911 | 5,933 | 5,727 | 5,749 | 5,655 | 5,607 | 5,565 | 5,497 | 5,460 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.5 | 1.2 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | 2.38 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 Nov 2025 |  Extraordinary General Meeting | NA | 12 Nov 2025 | 55.77 | 64.96 |
| 08 Sept 2021 |  Dividend | ₹ 0.50 /share | 07 Sept 2021 | 98.10 | 96.40 |
| 23 Sept 2022 | Dividend | ₹ 1.20 /share | 21 Sept 2022 | 83.05 | 66.35 |
| 09 Aug 2024 |  Annual General Meeting | NA | 09 Aug 2024 | 50.73 | 56.59 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 52.94 | 52.88 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 45.04 | 45.23 |
| 27 Mar 2025 | Extraordinary General Meeting | NA | 27 Mar 2025 | 43.01 | 41.38 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 41.03 | 40.32 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 39.36 | 42.31 |
| 27 Sept 2025 | Annual General Meeting | NA | 27 Sept 2025 | 38.41 | 35.00 |
Announcements
Extra-Ordinary General Meeting Of The Company To Be Held On Wednesday 12Th Day Of November 2025 At 10.00 A.M. Through
Video Conference / Other Audio-Visual Means (VC/OAVM)
5 days ago
5 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Preferential Issue7 days ago
7 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On 15.10.20257 days ago
7 days agoBoard Meeting Intimation for Prior Intimation Of Board Meeting For Consideration Of Fund-Raising ProposalOct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-RetirementOct 06, 2025
Oct 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Outcome Of 27Th Annual General Meeting Held On 27Th September2025.Sep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Intimation Of Book Closure And Cut-Off Date For The 27Th Annual General Meeting Of Jeevan Scientific Technology Limited.Sep 05, 2025
Sep 05, 2025Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference VC / Other Audio-Visual Means.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference "VC" I Other Audio-Visual Means.Sep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Aug 14, 2025Un Audited Financial Results For The Quarter Ended 30.06.2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for The Meeting To Be Held On 14.08.2025Aug 06, 2025
Aug 06, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 07.08.2025Aug 01, 2025
Aug 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 19, 2025
Jul 19, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
May 31, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
May 30, 2025Audited Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended 30.05.2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2025May 30, 2025
May 30, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30.05.2025May 26, 2025
May 26, 2025Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2025
Apr 30, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Apr 30, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Apr 15, 2025Information About Successful Completion Of Inspection Of JSTL Clinical And Bioanalytical Facilities By CDSCO (Central Drugs Standard Control Organisation) Under Regulation 30 Of SEBI (LODR) Regulations 2015.Apr 09, 2025
Apr 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 27, 2025
Mar 27, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMMar 27, 2025
Mar 27, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Mar 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Mar 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 17, 2025
Mar 17, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 17, 2025
Mar 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 05, 2025
Mar 05, 2025Notice Of Extra-Ordinary General Meeting To Be Held On 27Th March 2025 At 10:00 AM.Mar 03, 2025
Mar 03, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 01.03.2025Mar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Feb 08, 2025Copy Of News Paper Cuttings Of The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.Feb 08, 2025
Feb 08, 2025Integrated Filing (Financial)Feb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2025
Feb 06, 2025Integrated Filing (Financial)Feb 06, 2025
Feb 06, 2025Un Audited Results For The Quarter And Nine Months Ended 31.12.2024Feb 06, 2025
Feb 06, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2025Feb 06, 2025
Feb 06, 2025Board Meeting Intimation for Intimation For The Board Meeting To Be Held On 06.02.2025.Jan 30, 2025
Jan 30, 2025Technical Indicators
RSI(14)
Overbought 82.88
ATR(14)
Volatile 3.94
STOCH(9,6)
Overbought 94.99
STOCH RSI(14)
Overbought 89.49
MACD(12,26)
Bullish 2.64
ADX(14)
Strong Trend 46.05
UO(9)
Bearish 76.93
ROC(12)
Uptrend And Accelerating 66.44
WillR(14)
Overbought -5.86
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
